Forty years ago, with a small group of people armed with few resources but with many hopes and dreams, ELPEN began creating what would soon become a life time goal, a powerful and dynamic Greek pharmaceutical company.
Since its foundation, ELPEN is committed to offer high-quality pharmaceuticals and services. Our company's production know-how, superior product quality, and strategic marketing and sales techniques have not only won the confidence of the Greek medical and pharmaceutical communities, but these merits have in fact been acknowledged by several foreign companies, including multinationals, allowing thus, for the formation of solid partnerships with ELPEN.
Presently, we are enjoying long-lasting collaborations with multinational companies, in projects that are extremely successful, resulting in a significant profitability of the parties involved.
Our goal is to create business opportunities with reliable collaborators who wish to partner with ELPEN in order to either market their products in Greece or to market ELPEN's products in their Territories.
We are open to discuss all types of partnerships, including:
- Company representations
- licensing-in, co-marketing, co-promotion
- licensing-out (ELPEN products and services, link ELPENHALER®)
- contract manufacturing
Based on strategic planning, which includes international collaborations on several projects including proprietary Dry Powder Inhaler technology, the Elpenhaler®, and increasing resource allocation in the sector of research, ELPEN plans to expand into even more challenging goals.
The Elpenhaler® is Elpen's proprietary, Patent Protected, Breath-Activated, Multi Single-Dose Dry Powder Inhaler, initially developed for the administration of anti-asthma and COPD medications, which are packed in a specially designed single dose alu-alu blister strips.
ELPEN is seeking to license-out the Elpenhaler® line of anti-asthma and COPD products, which currently include products with active ingredients formoterol, fluticasone and selected combinations.
- Core Sales Territory:
Global Regulated Markets